Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Krystal Biotech, Inc./ 144

SEC Filing · 144

Krystal Biotech, Inc.

KRYSNASDAQEQUITYCurrent

SEC Filing

Filed Sep 4, 2026Accepted Sep 4, 2026, 4:34 PM EDTCIK 1711279Accession 0001950047-26-009149
View company →Permanent SEC source ↗
Share

Company context

Current securities

KRYSNASDAQ · EQUITY · Current

Recent company filings

  1. 4 filingSep 16, 2026
  2. 4 filingSep 16, 2026
  3. 4 filingSep 16, 2026
  4. 4 filingSep 4, 2026
  5. 4 filingSep 4, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗